Nature Clinical Practice Gastroenterology & Hepatology
Treatment Options for Esophageal Strictures CME

Disclosures

Release Date: February 5, 2008; Valid for credit through February 5, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    The content of this internet activity, "Treatment Options for Esophageal Strictures," was developed by the faculty.

    To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

    Esophageal strictures have been treated endoscopically for years, but new technology offers greater choices and greater efficacy in the management of strictures. The current review examines the current best practice for the treatment of esophageal strictures.

  1. Treatment Options for Esophageal Strictures
    Peter D. Siersema, MD, PhD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
WebMD
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Specify recommended stent types for the treatment of malignant esophageal strictures
  2. Describe the use of brachytherapy in the treatment of esophageal strictures
  3. Identify the most common cause of benign, simple esophageal strictures
  4. Describe the treatment of benign esophageal strictures
Authors and Disclosures

Peter D. Siersema, MD, PhD
Disclosure: Peter D. Siersema, MD, PhD, has disclosed no relevant financial relationships.


Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.